Facebook Pixel Saving Lives with BSL-4 Labs | Bio Spectrum - business - Magzter.comでこの記事を読む
Magzter GOLDで無制限に

Magzter GOLDで無制限に

10,000以上の雑誌、新聞、プレミアム記事に無制限にアクセスできます。

$149.99
 
$74.99/年

試す - 無料

Saving Lives with BSL-4 Labs

Bio Spectrum

|

February 2026

Starting a new era of India's health security, a biosafety level 4 (BSL-4) lab is being built at the cost of Rs 362 crore at Gujarat Biotechnology Research Centre in Gandhinagar. Although this will be India's second high-level lab after the National Institute of Virology in Pune (established in 2012), this is the first lab being built by a state government, with an area of 11,000 square metres. Back in 2024, the Defence Research and Development Organisation (DRDO) took a significant step in enhancing India's chemical-biological defence capabilities with the inauguration of a BSL-4 laboratory at the Defence Research and Development Establishment (DRDE) in Gwalior.

- Dr Manbeena Chawla

Saving Lives with BSL-4 Labs

India has been lagging behind for many years due to the cutting-edge research being done in the world, but the establishment of such BSL-4 bio-containment facilities in the country can provide new opportunities to the youth working in the biotechnology sector and help India emerge as a global leader in years to come.

According to reports, with 3,000 square metres of lab space, the Wuhan Institute of Virology in China is one the largest BSL-4 lab in the world, later overtaken by the National Bio and Agro-Defense Facility at Kansas State University in the US which boasts over 50,000 square metres of lab space including BSL-3 and BSL-4 facilities.

The global distribution of BSL-4 laboratories has evolved significantly over the past few decades, reflecting the growing recognition of the need for high-containment facilities in various regions. While historically concentrated in North America and Europe, there has been a notable increase in BSL-4 labs across Asia, Africa, and Australia in recent years.

Bio Spectrum からのその他のストーリー

Bio Spectrum

Bio Spectrum

Can India's CDMOS Lead the Next Biopharma Wave?

India's Contract, Development, and Manufacturing Organisation (CDMO) sector is projected to grow from $3-3.5 billion today to $22-25 billion by 2035, noted Boston Consulting Group (BCG).

time to read

8 mins

March 2026

Bio Spectrum

Bio Spectrum

Telangana turns catalyst for innovation

Telangana is at a pivotal moment in its journey as a global life sciences hub.

time to read

6 mins

March 2026

Bio Spectrum

Bio Spectrum

Is AI the New Weapon in the Fight to End TB?

A report released at the India AI Impact Summit 2026, organised by the Government of India, reveals that artificial intelligence (AI) is being successfully deployed at scale across India’s public healthcare system to address the growing burden of tuberculosis (TB).

time to read

2 mins

March 2026

Bio Spectrum

Bio Spectrum

ChemWerth on-boards Chandrakanth Reddy as new GSM to increase generic API footprint in India

US-based ChemWerth, Inc., a global leader in generic active pharmaceutical ingredient (API) development and supply, continues to expand its footprint and strengthen its position in the Indian market.

time to read

1 min

March 2026

Bio Spectrum

Bio Spectrum

Beyond the Glass Ceiling: Women-Led Companies Shaping India's Health Economy

Over the past decade, women entrepreneurs have gained strong ground in India's healthcare sector, building ventures in diagnostics, FemTech, biotech, and care delivery.

time to read

5 mins

March 2026

Bio Spectrum

Bio Spectrum

"There needs to be a collaborative effort between innovators and policymakers to create frameworks that ensure safety without stifling progress"

Started in 2021, Decode Age, one of the pioneers in Longevity Research in India, entered its next phase of growth following its Pre-Series A funding round, led by Granules India.

time to read

5 mins

March 2026

Bio Spectrum

Bio Spectrum

Rainbow Children's Medicare appoints Abrarali Dalal as Chief Executive Officer

Rainbow Children's Medicare, a leading provider of paediatrics, perinatal, and women's healthcare services in India, has announced the appointment of Abrarali Dalal as Chief Executive Officer, effective from January 20, 2026.

time to read

1 min

March 2026

Bio Spectrum

Bio Spectrum

Haleon ropes in Kedar Lele as President for India Subcontinent

Haleon, a British multinational consumer healthcare company has announced the appointment of Kedar Lele as President for India Subcontinent (ISC), effective January 2026.

time to read

1 min

March 2026

Bio Spectrum

Bio Spectrum

Centre revises Startup Recognition Framework to strengthen Startup India Action Plan

The government of India has revamped the Startup Recognition Framework to further strengthen the Startup India Action Plan and take forward the Prime Minister's vision of positioning India as a global innovation powerhouse, manufacturing-led economy and hub for emerging tech.

time to read

1 min

March 2026

Bio Spectrum

Bio Spectrum

"In the coming 5 years from now, no Indian CROS will grow or survive without the use of AI"

In January 2026, Ahmedabad-based Veeda Lifesciences announced a strategic leadership transition that marks a new chapter in the company's evolution.

time to read

5 mins

March 2026

Listen

Translate

Share

-
+

Change font size